Unanimous Support for AstraZeneca and Sanofi's Nirsevimab: Next Generation RSV Treatment on the Horizon -

Logo BenzingaBenzinga
2023-06-09 12:07:06  • 3 mins

The FDA's Antimicrobial Drugs Advisory Committee has voted unanimously 21 to 0 thatAstraZeneca plcAZN andSanofi SA'sSNY nirsevimab has a favorable benefit-risk profile to prevent respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants born during orentering their first RSV season.

The committee also voted 19 to 2 in support of nirsevimab's favorable benefit-risk profile for children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season.


The FDA accepted the marketing application for nirsevimab in 2022, and the agency has indicated it will work to expedite its review. The Prescription Drug User Fee Act date is in Q3 of 2023.

Nirsevimab will be available in the US before the 2023-2024 RSV season if approved by then.

ReutersnotesthatSwedish Orphan Biovitrum AB'sBIOVF Synagis is currently the only approved preventive therapy in the U.S. for high-risk infants against RSV.

Continue read on benzinga.com

Health care stocks were lower Thursday afternoon, with the NYSE Health Care Index falling 0.9% and the Health Care Select Sector SPDR Fund (XLV) down 0.5%....
Logo NasdaqNasdaq
2023-09-21 17:50:06  • 1 min
Fintel reports that on September 21, 2023, JMP Securities reiterated coverage of Aquestive Therapeutics ( NASDAQ:AQST ) with a Market Outperform...
Logo NasdaqNasdaq
2023-09-21 22:14:49  • 1 min
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator,...
Logo BenzingaBenzinga
2023-09-21 11:51:20  • 2 mins
The recent endorsement of an injectable medication to prevent HIV transmission by a leading health task force marks a key step in efforts to end the HIV...
Logo U.S. News & World ReportU.S. News & World Report
2023-09-21 15:02:22  • 1 min
What happened Shares of Calliditas Therapeutics (NASDAQ: CALT) were up more than 14% as of 1 p.m. ET on Thursday. The Swedish pharmaceutical company may have...
Logo NasdaqNasdaq
2023-09-21 18:32:43  • 1 min
By Denise Mann HealthDay Reporter WEDNESDAY, Sept. 20, 2023 (HealthDay News) -- In a surprising move, the U.S. Food and Drug Administration (FDA) has opted...
The FDA issued a Complete Response Letter regarding ARS Pharmaceuticals Inc's SPRY New Drug Application (NDA) for neffy (epinephrine nasal spray) in the...
Logo BenzingaBenzinga
2023-09-20 13:21:26  • 1 min
Fintel reports that on September 21, 2023, HC Wainwright & Co. maintained coverage of MediWound ( NASDAQ:MDWD ) with a Buy recommendation. Analyst Price...
Logo NasdaqNasdaq
2023-09-21 16:36:01  • 1 min
What happened Shares of Neumora Therapeutics (NASDAQ: NMRA) were down more than 32% for the week as of Thursday's market close, according to data provided by...
Logo NasdaqNasdaq
2023-09-21 22:06:04  • 1 min
Astellas Pharma Inc ALPMY ALPMF has elected not to exercise its option to obtain an exclusive license to TSHA-120 under the Option Agreement between Astellas...
Logo BenzingaBenzinga
2023-09-20 18:12:43  • 1 min
Key Points Certain people who got appointments for the latest Covid-19 vaccine formulation are receiving cancellation notices or showing up to learn there...
2023-09-21 21:39:11  • 1 min
(RTTNews) - Health Canada has issued a Notice of Compliance authorizing Vyvgart (efgartigimod alfa) for the treatment of generalized myasthenia gravis in...
Logo NasdaqNasdaq
2023-09-21 05:26:39  • 1 min
New Covid boosters from Pfizer and Moderna are now available at pharmacies nationwide. The Centers for Disease Control and Prevention (CDC) and Food and Drug...
Logo The IndependentThe Independent
2023-09-22 09:02:22  • 1 min
Key Takeaways: RemeGens sales expenses reached around 83% of sales income in the first half of the year and the company has flagged up a need for more...
Logo BenzingaBenzinga
2023-09-21 13:27:29  • 1 min
A month has gone by since the last earnings report for Medtronic (MDT). Shares have lost about 2.6% in that time frame, underperforming the S&P 500. Will...
Logo NasdaqNasdaq
2023-09-21 15:30:09  • 1 min
Swiss medical technology company Ypsomed YPHDF announced a long-term supply deal with Novo Nordisk A/S NVO for autoinjectors. Novo has been unable to keep...
Logo BenzingaBenzinga
2023-09-20 14:32:10  • 1 min
Heath care stocks were lower early Thursday morning as the Health Care Select Sector SPDR Fund (XLV) declined 0.6% and the iShares Biotechnology ETF (IBB)...
Logo NasdaqNasdaq
2023-09-21 13:40:47  • 1 min
(RTTNews) - SELLAS Life Sciences Group, Inc. (SLS) announced Thursday positive topline data for the patient group with relapsed/refractory (r/r) lymphomas...
Logo NasdaqNasdaq
2023-09-21 12:52:34  • 1 min
(RTTNews) - Jazz Pharmaceuticals plc (JAZZ) said that the European Commission granted marketing authorization for Enrylaze for use as a component of a...
Logo NasdaqNasdaq
2023-09-22 01:10:27  • 1 min
Fintel reports that on September 21, 2023, Baird upgraded their outlook for Healthequity ( NASDAQ:HQY ) from Neutral to Outperform. Analyst Price Forecast...
Logo NasdaqNasdaq
2023-09-22 00:44:49  • 1 min